SJCC Management Research Review

Open Access Open Access  Restricted Access Subscription Access

Acceptance of Erectile Dysfunction Drug Among Gen Y Men


Affiliations
1 CMS Business School, JAIN (Deemed to be University), Bangalore, India
2 JAIN (Deemed to be University), Bangalore, India
 

Erectile dysfunction (ED), defined as the difficulty to attain or maintain an erection firm enough to accomplish a satisfactory sexual intercourse. With the development of Medical Science ED Drug are developed to encounter such problems. The primary objective of this research paper focuses on acceptance of ED Drug by Generation Y. The primary data is collected through structured questionnaire specific for male respondents within the age group of 18-35 years with the sample size of 150. The reliability of data was verified using KMO & Bartlett's and Test Reliability Statistics. A structured questionnaire is developed and validated. It is sent to the respondents via Google form and the responses are recorded, validated and analysed further for desired results. Research focused on Gen Y men (age group of 18-35). The data clearly show that 64.7 percent of the people feel that use of ED drugs would help them last longer in bed with their partner. Awareness about ED drug will provide the young men to be more proactive towards their sexual health.

Keywords

ED Drug, Psychology, Satisfaction, Performance Risk, Gen Y, Erectile Dysfunction.
User
Notifications
Font Size

  • Ayta IA, McKinlay JB, Krane RJ (1999): The likely worldwide increase in erectile dysfimction between 1995 and 2025 and some possible policy consequences. BJU Int.; 84(1):50-6.

  • Care, V. H. (July 2013). Erectile Dysfunction. 1, 2.

  • Jonler, M., Moon, T., Brarman, W. et al (1995). The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol.; 75:651.

  • Hong, E.K., Lepor, H., McCullough, A.R. (1999): Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical refro pubic prostatectomy (RRP). Int J Impot Res. 11:S15.

  • Jarow, J.R, Burnett, A.L., Geringer, A.M. (1999). Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol.; 162:722.

  • Care, V. H. (July 2013). Erectile Dysfimction. 1,2.

  • H Padma-Nathan, C. S. (26 February 2003). The efficacy and safety of a topical alprostadil cream, Alprox-TD®, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.

  • K. Hatzimouratidis (Chair), I. E. (March 2015). Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature ejaculation.

  • KOICHI NAGAO, H. K. (2008). Large-scale questionnaire survey of erectile dysfunction drugs in Japanese men. 1,2.

  • Limited, B. A. (June 2017). Phosphodiesterase type 5 inhibitors for erectile dysfunction.

  • Michael Perelman, P. R. (2005). Attitudes of Men with Erectile Dysfunction: A Cross-National Survey. 1,2.

  • Patel, C. K. (18TH March, 2016). Advances in the treatment of erectile dysfunction: what's new and upcoming? 1,2.

  • Rupesh Raina, M. M. (2003). Long-Term Effect Of Sildenafil Citrate On Erectile Dysfunction After Radical Prostatectomy: 3-Year Foliow-Up. 1,2,3.

  • Montorsi F, Adaikan G, Becher E, et al.: Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010; 7(11).

  • Derogatis LR, Burnett AL: The epidemiology of sexual dysfunctions. J Sex Med. 2008; 5(2):289-300.

  • Ayta lA, McKinlay JB, Krane RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999; 84(1):50-6.

  • Selvin E, Burnett AL, Platz EA: Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 200; 120(2).


Abstract Views: 161

PDF Views: 98




  • Acceptance of Erectile Dysfunction Drug Among Gen Y Men

Abstract Views: 161  |  PDF Views: 98

Authors

S. Hemanth Kumar
CMS Business School, JAIN (Deemed to be University), Bangalore, India
T. R. Chetan
JAIN (Deemed to be University), Bangalore, India

Abstract


Erectile dysfunction (ED), defined as the difficulty to attain or maintain an erection firm enough to accomplish a satisfactory sexual intercourse. With the development of Medical Science ED Drug are developed to encounter such problems. The primary objective of this research paper focuses on acceptance of ED Drug by Generation Y. The primary data is collected through structured questionnaire specific for male respondents within the age group of 18-35 years with the sample size of 150. The reliability of data was verified using KMO & Bartlett's and Test Reliability Statistics. A structured questionnaire is developed and validated. It is sent to the respondents via Google form and the responses are recorded, validated and analysed further for desired results. Research focused on Gen Y men (age group of 18-35). The data clearly show that 64.7 percent of the people feel that use of ED drugs would help them last longer in bed with their partner. Awareness about ED drug will provide the young men to be more proactive towards their sexual health.

Keywords


ED Drug, Psychology, Satisfaction, Performance Risk, Gen Y, Erectile Dysfunction.

References